换一批
换一批Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing.
作者：
主题词
动物(Animals);抗生素类, 抗肿瘤(Antibiotics, Antineoplastic);细胞增殖(Cell Proliferation);疾病模型, 动物(Disease Models, Animal);剂量效应关系, 药物(Dose-Response Relationship, Drug);多柔比星(Doxorubicin);药物筛选试验, 抗肿瘤(Drug Screening Assays, Antitumor);女(雌)性(Female);人类(Humans);脂质体(Liposomes);发光测定法(Luminescent Measurements);肿瘤, 实验性(Neoplasms, Experimental);粒子大小(Particle Size);血浆去除术(Plasmapheresis);聚乙烯二醇类(Polyethylene Glycols);大鼠(Rats);大鼠, 近交F344(Rats, Inbred F344);表面特性(Surface Properties);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.2174/1567201815666180518125839
PMID
29779479
发布时间
2020-02-25
- 浏览16
Current drug delivery
1261-1270页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
